×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Practical Decision Making across the lifecycle: Bayesian Approaches
Session Chair(s)
Richardus J Vonk
Head of Research and Clinical Sciences Statistics
Bayer AG, Germany
Practical Decision Making across the lifecycle: Bayesian Approaches
Speaker(s)
A Bayesian-based Clinical Utility Index for Dose Determination in Drug Development: Design space thinking applied to clinical development
Bruno Boulanger
Arlenda, Belgium
CSO
The Contribution of Bayesian Methodology to Quantitative Decision Making in Drug Development
Andrew Peter Grieve, DrSc, PhD, MSc
Aptiv Solutions, Germany
Senior Vice President Clinical Trial Methodology
Assesing Phase 3 Success Probabilities in Phase 2. A Bayesian Approach
Tony Sabin
Amgen Ltd. , United Kingdom
Director, Biostatistics
Have an account?